Dyadic International/DYAI

$1.50

-1.96%
-
1D1W1MYTD1YMAX

About Dyadic International

Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila). Its lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

Ticker

DYAI

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Mark Emalfarb

Employees

7

Headquarters

Jupiter, United States
Website
dyadic.com

DYAI Metrics

BasicAdvanced
$46.07M
Market cap
-
P/E ratio
-$0.24
EPS
0.60
Beta
-
Dividend rate
$46.07M
0.59691
$2.40
$1.19
23.84K
3.583
-61.97%
-80.11%
-78.87%
15.892
7.793
7.837
-1.07%
31.3%
21.86%

What the Analysts think about DYAI

Analyst Ratings

Majority rating from 1 analysts.
Buy

Price Targets

Average projection from 2 analysts.
400% upside
High $9.00
Low $6.00
$1.50
Current price
$7.50
Average price target

DYAI Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-333.33% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$600K
100%
Net income
$-2M
25%
Profit margin
-333.33%
-37.5%

DYAI Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 23.08%
QuarterlyAnnual
Q3 22
Q4 22
Q2 23
Q3 23
Q4 23
Actual
-$0.06
-$0.07
-$0.07
-$0.06
-$0.08
Expected
-$0.10
-$0.09
-$0.05
-$0.06
-$0.07
Surprise
-36.84%
-17.65%
40%
0%
23.08%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Dyadic International stock?

Dyadic International (DYAI) has a market cap of $46.07M as of April 23, 2024.

What is the P/E ratio for Dyadic International stock?

The price to earnings (P/E) ratio for Dyadic International (DYAI) stock is 0 as of April 23, 2024.

Does Dyadic International stock pay dividends?

No, Dyadic International (DYAI) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next Dyadic International dividend payment date?

Dyadic International (DYAI) stock does not pay dividends to its shareholders.

What is the beta indicator for Dyadic International?

Dyadic International (DYAI) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Dyadic International stock price target?

The target price for Dyadic International (DYAI) stock is $7.5, which is 400% above the current price of $1.5. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Dyadic International stock

Buy or sell Dyadic International stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing